Full-Time

DEXIS Quality Assurance Manager

Confirmed live in the last 24 hours

Envista

Envista

1,001-5,000 employees

Global provider of dental products and technologies

Compensation Overview

$89.3k - $165.8k/yr

+ Bonus + Medical Benefits + Dental Benefits + Vision Benefits + 401K Match

Senior

Quakertown, PA, USA

Category
QA & Testing
Quality Assurance
Required Skills
Data Analysis
Requirements
  • Bachelor's degree; preferably in Engineering, Life Science, or similar technical field
  • 5+ of experience in the medical device industry.
  • 3+ direct supervisory and decision-making experience.
  • Knowledge of FDA regulations, ISO 13485 MDSAP, EU MDR
  • Proficient use of computers, MS-Office (Word, PowerPoint, and Excel knowledge required).
  • Capable of communicating with clarity within team, cross-functional departments, and management.
  • Capable of making decisions for day-to-day activities.
  • Demonstrated ability to teach and mentor.
  • Ability to analyze and assimilate data including engineering drawings, specifications, labeling, statutory and regulatory requirements.
  • Self-motivated and able to work with minimum supervision.
Responsibilities
  • Overseeing end-to-end process of receiving, reviewing, documenting, investigating, and resolving complaints related to our medical devices in compliance with regulatory requirements and within process timeframes.
  • Analyzing and reporting of KPIs related to supplier and product quality and overseeing initiatives to drive to KPI targets.
  • Conduct thorough investigations into reported complaints, collaborating with cross-functional teams to ensure complaint data accuracy, identify root causes, assess potential risks, and implement corrective and preventive actions (CAPAs).
  • Maintain accurate and comprehensive records of all complaints, investigations, incident/event reportable, and resolutions, ensuring adherence to regulatory standards and internal procedures.
  • Stay updated with relevant regulations and standards (e.g., FDA, ISO) and ensure that quality processes align with regulatory requirements.
  • Collaborate with Tech Support, Customer Service, Engineering, Quality Assurance, and Regulatory Affairs teams to assess trends, identify areas for improvement, and contribute to the development of quality systems and processes.
  • Prepare and present reports on complaint trends, investigation outcomes, and risk assessments to internal stakeholders and regulatory agencies as necessary.
  • Maintain and drive improvements of the supplier quality management program.
  • Oversee management of supplier files, including oversight and review of the Approved Suppliers List.
  • Manage and support supplier audits.
  • Manage and support the issuance and review of Supplier Corrective Action Requests, reviewing for accuracy and confirming effectiveness of the Corrective Action.
  • Oversee the internal non-conforming parts/products process and the Material Review Board.
  • Utilize established business tools (EBS) to drive continuous improvement of processes to further streamline and automate complaint data processing.
  • Identify, initiate, and support product quality initiatives.
  • Training of Quality Assurance Specialists and other team members.
  • Other duties as assigned.
Desired Qualifications
  • Experience with FDA regulations, ISO 13485 MDSAP, EU MDR
  • Strong knowledge of complaint processes and adverse event reporting.
  • Excellent analytical skills with the ability to conduct thorough investigations and root cause analyses.
  • SAP ERP and document control experience.
  • Experience with Microsoft Dynamics CRM.
  • Knowledge of GMP and Quality Systems in a regulated industry (medical device or pharmaceutical area).
  • Exceptional organizational skills and attention to detail to maintain accurate documentation and records.
  • Effective interpersonal and communication skills with the ability to collaborate cross-functionally, interact with customers professionally and empathetically, and work with minimum supervision.
  • Certification in quality management (e.g., Certified Quality Auditor - CQA) is a plus.

Envista provides a wide range of dental products and services aimed at supporting dental professionals in their work. Their product portfolio includes dental implants, orthodontics, and digital imaging technologies, which together address about 90% of the clinical needs for diagnosing, treating, and preventing dental conditions. Envista's products are designed to help dental professionals create healthy and aesthetically pleasing smiles for their patients. What sets Envista apart from its competitors is its commitment to continuous improvement and a strong partnership with dental professionals, ensuring they have the support they need to succeed. The company's goal is to empower dental professionals to excel in their practice and enhance the confidence of their patients.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Brea, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Growing demand for AI-powered dental imaging boosts Envista's innovation potential.
  • Teledentistry rise complements Envista's Smile Project for underserved communities.
  • Sustainability focus aligns with Envista's ESG commitments in their 2023 report.

What critics are saying

  • Emerging dental tech companies threaten Envista's market share with innovative solutions.
  • Rapid AI advancements could outpace Envista's current technological offerings.
  • Supply chain vulnerabilities may disrupt Envista's product availability.

What makes Envista unique

  • Envista covers 90% of dentists' clinical needs with a comprehensive product portfolio.
  • Envista's Smile Project has donated $4.2 million in dental goods since 2021.
  • Envista's DEXIS brand leads in AI-powered dental imaging solutions.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

Performance Bonus

Company News

PR Newswire
Feb 25th, 2025
Envista Smile Project Donates $1.8 Million In 2024

BREA, Calif., Feb. 25, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") proudly announced that in 2024, the Envista Smile Project (Smile Project) contributed $1.8 million to further its mission of enhancing oral health accessibility for underserved communities.Since its inception in 2021, the Envista Smile Project has delivered over $4.2 million in dental goods and services, positively impacting approximately 32,000 individuals worldwide.In 2024, the Envista Smile Project:Supplied free dental care to more than 787 patients in the Dominican Republic. Donated goods for cleaning, cavity prevention and treatment, and consumables to free dental clinics managed by Heartland Dental and the Illumination Foundation totaling more than 5,600 patients.Provided portable x-ray access to the Colorado Mission of Mercy, Rhode Island Mission of Mercy, New Mexico Mission of Mercy, Nurturing Smiles, Seattle /King County Clinic, Michigan Dental Association, and Special Olympics New Jersey./King County Clinic, Michigan Dental Association, and Special Olympics New Jersey. Partnered with the University of Southern California's ( USC ) Herman Ostrow School of Dentistry to support USC's Dental Health Equity and Access to Care Initiative.( ) of Dentistry to support Dental Health Equity and Access to Care Initiative. Sponsored five senior residents to Jamaica with Great Shape/1000 Smiles, where they treated over 1661 patients with no access to oral care."At Envista, we believe that oral health is a fundamental part of overall well-being, and we are proud to support communities in need through the Smile Project," said Rubin Casas, Envista Smile Project Board President. "By working alongside dedicated dental professionals and volunteers, we continue to make a meaningful impact—restoring smiles, improving health, and changing lives."Envista Smile Project is a philanthropic foundation designed to improve the oral health of disadvantaged communities by supporting increased access to oral care and oral health education

PR Newswire
Feb 4th, 2025
Envista To Hold Capital Markets Day On March 5, 2025

BREA, Calif., Feb. 4, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will hold a Capital Markets Day on Wednesday, March 5, from 9:00 a.m. to 12:00 p.m. EST. This event will include a management presentation followed by a question-and-answer session. In-person attendance requires advanced registration

PharmiWeb
Feb 3rd, 2025
Dexis Reflects On A Year Of Innovation And Unveils Exciting Plans For 2025

QUAKERTOWN, PENNSYLVANIA / ACCESS Newswire / February 3, 2025 / DEXIS, an international leader in dental imaging technologies, celebrates the 2024 launch of its DEXIS digital ecosystem along with other AI-powered imaging solutions. The company also announces that 2025 will bring further innovations, with presentations at two major dental technology conferences."For DEXIS, 2024 was a year of tremendous innovation, as we continue to provide dental professionals with the most powerful, efficient and time-saving diagnostic tools and technologies," DEXIS President Robert Befidi said. "We are proud of our progress and will bring that momentum with us in 2025 as we unveil exciting, industry-changing initiatives."The company enhanced its portfolio of award-winning imaging solutions in 2024, beginning with the February 2024 launch of the DEXIS digital ecosystem , a suite of tools and software designed to connect and streamline the implant workflow. The platform combines cutting-edge CBCT, intraoral scanning, diagnostics, and treatment planning to aid clinicians through their entire digital workflow from diagnosis to delivery. The open imaging system ensures that clinicians have the freedom to customize workflows and that patients, labs, and staff have the appropriate visibility, creating a seamless experience.May 2024 brought the release of the DEXIS Ti2 Intraoral Sensor , built on the success of its predecessor, the best-selling DEXIS Titanium Sensor. The Ti2 sensor provides high-resolution images while also adding 2D AI Dental Findings, an integrated offering that automatically identifies and highlights 6 common dental findings

PR Newswire
Jan 27th, 2025
Update: Envista Schedules Fourth Quarter 2024 Earnings Call

BREA, Calif., Jan. 27, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista is moving the time of the conference call and will now discuss these results beginning at 2:30 PM PT on the same date. The call will last approximately one hour.The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S

PR Newswire
Jan 14th, 2025
Envista Schedules Fourth Quarter 2024 Earnings Call

BREA, Calif., Jan. 14, 2025 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its fourth quarter 2024 on Wednesday, February 5, 2025. Envista will discuss these results on a conference call on the same day beginning at 2:00 PM PT and lasting approximately one hour.The call and the accompanying slide presentation will be webcast on the "Investors" section of Envista's website, www.envistaco.com. A replay of the webcast will be available shortly after the conclusion of the presentation and will remain available for one year. You can access the conference call by dialing 800-225-9448 within the U.S. or +1 203-518-9708 outside the U.S